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Oxidant generation is part of the normal
metabolism of many cell types and is critical
for homeostasis. Humans have evolved an
antioxidant system to protect against oxida-
tive stress—a state of imbalance between oxi-
dant production and antioxidant defenses.
Inhaled toxicants such as air pollutants and
tobacco smoke can increase oxidative stress
(Long et al. 2001; Morrow et al. 1995;
Sorensen et al. 2003) through direct genera-
tion of reactive oxygen species (ROS) and
through activation of inflammatory leuko-
cytes. Inflammatory cells respond with the
“respiratory burst” that involves the uptake of
oxygen and release of ROS into the cellular
surroundings. Inhaled air pollutants such as
ozone interact directly with biomolecules in
the respiratory tract lining fluid (RTLF),
including unsaturated lipids, nucleic acids,
and proteins (Mustafa 1990), damage that is
reﬂected in peripheral blood.
Lipid peroxidation occurs when lipids are
attacked by free radical species and hydrogen
atoms are extracted from the methylene carbon
side chain, initiating a cascade of free ROS
that can cause oxidative damage to cell struc-
tures (Mudway and Kelly 2000; Pryor 1994).
To terminate these events, radicals need to
react with each other to create a nonradical
species or be quenched by an antioxidant
(Halliwell and Chirico 1993). This secondary
inflammatory cell response to the initial
oxidative damage results in F2-isoprostanes for-
mation, which may contribute to lung injury.
F2-isoprostanes are a recently discovered
series of bioactive prostaglandin F2-like com-
pounds produced independently of the
cyclooxygenase enzymes via arachadonic acid
(AA) peroxidation (Morrow and Roberts
2002). A substantial portion of isoprostanes
undergoes β-oxidation in tissues before their
release into plasma. Of these, mainly 8-iso-
prostaglandins-F2α (8-iso-PGF) are formed
continuously under normal physiological con-
ditions and can be found at elevated levels as a
result of environmental exposures, including
O3 and cigarette smoke (Chiabrando et al.
1999; Montuschi et al. 2000; Obata et al.
2000). Chamber studies have shown increased
levels of 8-iso-PGF after 1 hr (Devlin et al.
1996; Hazbun et al. 1993) and 4 hr of expo-
sure to O3 in healthy subjects (Montuschi
et al. 2002). A recent study found increased
plasma levels of 8-iso-PGF in both smokers
and nonsmokers after multiday exposure to
tobacco smoke (Ahmadzadehfar et al. 2006),
an observation that suggests that chronic
exposure may increase oxidative stress.
Clinical studies have shown that in addi-
tion to the peroxidation of AA, 8-iso-PGF
also reﬂects the redox status of the microenvi-
ronment (Lawson et al. 1999). 8-iso-PGF and
other indicators of redox status have been used
as markers of asthma severity (Nadeem et al.
2003) and chronic obstructive pulmonary
disease (COPD) (Nadeem et al. 2005; Rahman
et al. 1996). Redox status can serve as an
important marker of an individual’s response to
oxidative stress and is cost-effective to analyze
in large epidemiologic studies.
Overall antioxidant capacity is a potential
modifying factor of an individual’s response
to oxidative stress. One such marker is the
ferric reducing ability of plasma (FRAP) assay
(Benzie and Strain 1996) in which a ferric-to-
ferrous ion reduction at low pH causes a
colored ferrous–tripyridyltriazine (TPTZ)
complex to form. Absorbance changes are lin-
ear over a wide concentration range in antiox-
idant mixtures, including plasma. The FRAP
assay has been used in studies on effects of
pesticide exposure (Ranjbar et al. 2002) and
vitamin supplementation on cardiovascular
health (Bub et al. 2002).
Chronic airway diseases [e.g., asthma and
COPD (Rahman et al. 2006)] and systemic
diseases [e.g., atherosclerosis and diabetes melli-
tus (Kaneto et al. 2007; Papaharalambus and
Griendling 2007)] are associated with increased
oxidative stress and lipid peroxidation.
In the present study we explore the associ-
ation between O3 exposure and markers of
lipid peroxidation and antioxidant capacity in
healthy students from the University of
California, Berkeley (UCB), who experienced
different seasonal and geographic levels of O3
overtheir lifetimes and during recent summer
vacation in either greater Los Angeles (LA) or
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BACKGROUND: There is growing evidence for the role of oxidative damage in chronic diseases.
Although ozone (O3) is an oxidant pollutant to which many people are exposed, few studies have
examined whether O3 induces oxidative stress in humans.
OBJECTIVES: This study was designed to assess the effect of short- and long-term O3 exposures on
biomarkers of oxidative stress in healthy individuals.
METHODS: Biomarkers of lipid peroxidation, 8-isoprostane (8-iso-PGF), and antioxidant capacity
ferric reducing ability of plasma (FRAP) were analyzed in two groups of healthy college students
with broad ranges of ambient O3 exposure during their lifetimes and previous summer recess either
in Los Angeles (LA, n = 59) or the San Francisco Bay Area (SF, n = 61).
RESULTS: Estimated 2-week, 1-month, and lifetime O3 exposures were signiﬁcantly correlated with
elevated 8-iso-PGF. Elevated summertime exposures resulted in the LA group having higher levels
of 8-iso-PGF than the SF group (p = 0.02). Within each location, males and females had similar
8-iso-PGF. No regional difference in FRAP was observed, with signiﬁcantly higher FRAP in males
in both groups (SF: p = 0.002; LA: p = 0.004). An exposure chamber substudy (n = 15) also showed
a signiﬁcant increase in 8-iso-PGF as well as an inhibition of FRAP immediately after a 4-hr expo-
sure to 200 ppb O3, with near normalization by 18 hr in both biomarkers.
CONCLUSIONS: Long-term exposure to O3 is associated with elevated 8-iso-PGF, which suggests
that 8-iso-PGF is a good biomarker of oxidative damage related to air pollution.
KEY WORDS: antioxidant capacity, FRAP, isoprostane, lifetime exposure, lipid peroxidation, plasma,
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acutely exposed to O3 in a controlled envi-
ronment. This is an extension of a larger pro-
ject examining the effect of lifetime O3
exposure on lung function in young adults
(Tager et al. 2005).
Materials and Methods
Study participants and sample collection. The
overall design of the study, presented in detail
by Tager et al. (2005), included 255 ﬁrst-year
undergraduates at UCB, who were recruited
for enrollment over a 2-year period. In this
biomarker study, we used a subcohort of par-
ticipants (n = 120) enrolled between February
and the ﬁrst week of June 2002, each of whom
provided blood samples (Table 1). Eligibility
was based on the following: a) lifelong resi-
dence in either LA or SF, b) lifetime never
smoker, and c) no history of chronic respira-
tory disease. The majority of participants were
Asian (50%) or Caucasian (35%). Hispanics
(n = 10), African Americans (n = 1), and sub-
jects with other ethnic backgrounds (n = 7)
were pooled together as “Others” for statistical
analysis. Lifetime residents of SF composed
51% of the subjects; 56.6% of all subjects were
females. By design, ages ranged from 18 to
22 years. During the first 8–12 days of each
subject’s return to UCB from summertime resi-
dences in LA or SF (August–early September
2002), a trained phlebotomist collected small
samples of peripheral blood. Plasma was sepa-
rated from red blood cells and stored in
aliquots at –80°C until use. Spirometry was
performed as previously described (Tager et al.
2005) and included lung function measures of
forced expiratory volume in 1 sec (FEV1),
forced expiratory flow rate between 25 and
75% (FEF25–75), forced expiratory flow rate
at 75% (FEF75), and forced vital capacity
(FVC). We also obtained a complete history of
summertime (June–August) residences.
Exposure assessment. The details for the
assessment of lifetime exposure to O3 have been
described previously (Kunzli et al. 1997; Tager
et al. 2005). We reconstructed lifetime residen-
tial history with a standardized questionnaire;
air pollutant [O3, particulate matter with an
aerodynamic diameter of ≤ 10 µm (PM10), and
nitrogen dioxide (NO2)] concentrations were
assigned for each month of life to each residen-
tial location. Air quality data were acquired
from the California Air Resources Board (ARB,
compact disc no. PTSD-02-017-CD), the
Aerometric Information Retrieval System, and
from special requests to ARB. We interpolated
monthly mean measures of O3 spatially from
air quality monitoring stations to the residence
locations with inverse distance weighting and a
maximum of three monitoring stations for each
interpolation (maximum interpolation radius of
50 km). Lifelong residents of LA had signiﬁ-
cantly higher estimated lifetime O3 exposure
than SF residents (Table 1). Based on the same
interpolation methods, we calculated estimates
of short-term exposure to O3 based on the
moving averages of 8-hr maximum O3 concen-
trations 1–30 days prior to the day of blood
collection. Although both 1- and 8-hr maxi-
mum O3 average levels in LA (0.12 and
0.10 ppm, respectively) during summer were
almost double those of SF (0.07 and 0.05 ppm,
respectively), individual exposures from up to
1 month before blood collection from subjects
in this study overlapped signiﬁcantly (Table 1).
Controlled O3 exposure substudy. The
design of this substudy has been described
previously (Chen et al. 2006). Brieﬂy, we col-
lected peripheral blood from 15 volunteers
from the main cohort before and 18 hr after
4 hr of exposure to 200 ppb O3 in a chamber
with intermittent exercise (30 min of each
hour). Four subjects also donated blood
immediately after exposure. We conducted
chamber studies during the spring when
ambient exposures are relatively low and
when all study participants had been in SF for
several months. Nine of the 15 subjects grew
up in SF.
The Committee of the Protection of
Human Subjects, UCB, and the Committee
on Human Research, University of California,
San Francisco, approved all protocols for this
study, and we obtained written informed con-
sent from all subjects.
8-Iso-PGF and FRAP assays validation
and quality assurance. We conducted several
pilot experiments prior to the study. The pre-
cision of both the 8-iso-PGF and FRAP
assays, expressed as the coefﬁcient of variation
(CV% = (SD ÷ mean) × 100), was deter-
mined from triplicate assays of repeated sam-
ples from five laboratory controls with
characteristics similar to those of the main
study population. Separate plates were ana-
lyzed, and the CV% for the same control sam-
ple across several experiments fell below 10%
for 8-iso-PGF and below 7% for FRAP. We
performed additional quality assurance/
quality control (QA/QC) studies to determine
if any artifactual formation of 8-iso-PGF levels
in plasma could result from sample processing
and storage. We compared four conditions for
biological processing over a 7-day period:
a) storage at –80°C after separation of plasma
from red blood cells immediately after blood
draw; b) storage at –20°C immediately;
c) blood samples left at room temperature
5 hr, then at –80°C for the remainder of
7 days; and d) storage at –4°C for 5 hr, then at
–80°C, mimicking the biological sample pro-
cessing condition for this study. All conditions
showed similar results with good reproducibil-
ity. Results of storage over the 2-week pilot
study were comparable with those stored for
several months and those reported in previ-
ously published studies. All samples, internal
positive controls, and randomly distributed
blanks were run in triplicate (variability < 3%,
8-iso-PGF, and < 5%, FRAP).
8-Iso-PGF assay. Lipid peroxidation was
measured by a competitive enzyme-linked
immunosorbent assay (ELISA) for 8-iso-PGF
with a commercial kit (Cayman Chemical,
Ann Arbor, MI). To prevent cross-reactivity,
we puriﬁed plasma samples by afﬁnity sorbent
chromatography columns in accordance with
the manufacturer’s protocol. The assay is
based on the competition between 8-iso-PGF
and 8-isoprostane–acetylcholinestase (AChE)
conjugate for a limited number of binding
sites in each ELISA plate well. The concentra-
tion of 8-iso-PGF is inversely proportional to
the number of binding sites available, whereas
AChE is held constant. Samples were applied
to the column followed by several washes. The
last wash that contained puriﬁed 8-iso-PGF in
the eluate was dried by vacuum centrifugation.
We reconstituted the resulting pellet in phos-
phate buffer (Cayman Chemical, Ann Arbor,
MI) and transferred to the ELISA plate. The
absorbance of the colorimetric enzymatic reac-
tion was read at 405 nm using the SpectraMax
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Table 1. Cohort characteristics.
Characteristic LA SF Total
No. of subjects 59 61 120
Sex (% female) 56.9 57.3 56.6
Ethnicity (%)
Caucasian 45.8 54.1 50
Asian 30.5 41.0 35.8
Other 23.7 4.9 14.5
Age (years) 19 (19–20) 19 (18-22) 19 (18–22)
Weight (kg) 62.3 (46.8–97.0) 62.5 (40.9–113.9) 62.4 (40.9–113.9)
BMI 22.4 (17.2–37.4) 21.8 (16.8–32.2) 22.2 (16.8–37.4)
Recent O3 exposures (8-hr moving averages, ppb)
2 week 30.7 (14.3–43.1) 30.9 (13.5–47.9) 30.8 (13.5–47.9)
1 month 28.4 (5.0–41.8) 28.1 (14.1–43.1) 28.3 (5.0–43.1)
Lifetime exposure (estimated monthly average, ppb)
O3 42.9 (28.5–65.3) 26.9 (17.6–33.5) 30.5 (17.6–65.3)
PM10(before 1987) 92.0 (63.9–124.2) 52.6 (34.2–89.6) 68.1 (34.2–124.2)
PM10 (after 1987) 42.3 (25.7–67.9) 25.6 (17.8–28.6) 28.5 (17.3–67.9)
NO2 39.7 (8.3–49.9) 21.6 (11.4–29.6) 26.9 (8.3–49.9)
Data are presented as either percentage or median (range).Plus microplate reader (MDS Analytical
Technologies, Sunnyvale, CA) and compared
with an 8-iso-PGF standard curve to calculate
concentration.
FRAP assay. Antioxidant capacity was
measured with the FRAP assay (Benzie and
Strain 1996). Nonhemolyzed plasma samples
were selected and analyzed in triplicate. Color
change in the biological sample, measured at
593 nm wavelength 4 min after adding the
FRAP reagent (acetate buffer, TPTZ, FeCl3 •
H2O), is directly proportional to the combined
reducing power of the antioxidants in the reac-
tion mixture. Samples were run against inter-
nal antioxidant standards (α-tocopherol,
Fe(II), uric acid, L-ascorbic acid). The analysis
was performed in a 96-well plate with the
SpectraMax Plus microplate reader.
Statistical analysis. We performed statisti-
cal analysis with SAS 9.1 software (SAS
Institute Inc., Cary, NC). FRAP levels were
distributed normally; 8-iso-PGF levels were
log-transformed to normalize the distribution.
Student t-test was used to determine log
8-iso-PGF and FRAP differences by sex and
geographic location. The nonparametric
Wilcoxon signed-rank tests for 8-iso-PGF lev-
els yielded the same results as the t-tests (results
not shown). We used analysis of variance
(ANOVA) to determine differences between
the three ethnicity groups (coded as dummy
variables: 0 = Caucasian, 1 = Asian American,
2 = Other). Bivariate analysis and correlations
between log 8-iso-PGF, body mass index
(BMI), weight, FRAP, and daily exposure to
O3 up to 30 days before blood collection were
determined by Pearson correlation coefﬁcients.
Multivariable analyses were conducted after
examination of potential effect modiﬁers. Sex,
ethnicity, BMI, FRAP levels, and O3 exposure
estimates were included if they were statistically
significant based on type III sum of squares.
We ran models that included weight rather
than BMI, but the results did not change sig-
niﬁcantly. However, because weight and BMI
are collinear, we chose to use BMI, as it takes
into account both height and weight. We also
explored the effect of these biomarkers on lung
function multivariable regression based on
models that have been optimized previously for
this cohort (Tager et al. 2005). The effect of
age was not adjusted for in these models
because of the narrow age range of subjects in
the study.
Results
The distributions of the two biomarkers of
oxidative stress, 8-iso-PGF and FRAP, in the
study population are presented in Figures 1
and 2. Levels of 8-iso-PGF had wide interindi-
vidual variability (range, 17.4–940.7 pg/mL).
Subjects from LA who were exposed to twice
the level of O3 during the summer compared
with those spending their summer in SF had,
on average, 2-fold higher 8-iso-PGF (Table 2,
p = 0.02, unpaired t-test). Levels of 8-iso-PGF
did not vary significantly by sex (p = 0.81).
Comparisons of 8-iso-PGF levels between
sexes by the two geographic regions, LA and
SF were not signiﬁcant (p = 0.78 and p = 0.42
for men and women, respectively). Although
there was no significant difference in 8-iso-
PGF levels between the two predominant eth-
nicities, Caucasian and Asians, there was a
suggestion that the “Other” ethnic group had
increased 8-iso-PGF levels (p = 0.07).
However, because of the small numbers, no
one subgroup of the heterogeneous “Other”
group could be identiﬁed as responsible for the
difference. No correlation was observed
between individual 8-iso-PGF and weight (r =
0.10, p = 0.27) or BMI (r = 0.12, p = 0.19).
FRAP levels ranged from 637.2 to
1908.9 µmol/mL. In contrast to 8-iso-PGF,
FRAP levels did vary by sex (Figure 2B,
p = 0.002) but not by geographic region
(Figure 1B, p = 0.52). However, when com-
parisons between sexes by the two geographic
regions were carried out, males had higher lev-
els in both regions (p = 0.009 and p = 0.003,
respectively). FRAP was also signiﬁcantly cor-
related with weight (r = 0.40, p = 0.0002) and
marginally correlated with BMI (r = 0.19, p =
0.09). Ethnicity was not associated with
antioxidant capacity (Table 2, p = 0.32). FRAP
levels were not correlated with 8-iso-PGF
(r = –0.08, p = 0.47).
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Table 3. Exposure models for predictors of 8-iso-PGF in healthy young adults.
Model
O3 measure 1 2 3 Full
2 weeks 0.035 (0.015)* 0.023 (0.010)*
1 month 0.031 (0.013)* 0.025 (0.009)*
Lifetime 0.024 (0.008)* 0.023 (0.006)*
Data are presented as coefﬁcient (SE). Outcome of 8-iso-PGF was log-transformed to normalized distribution. Units for para-
meter estimates are log 8-iso-PGF/change in O3 measure (8-iso-PGF: pg/mL; O3 measure: 2 weeks, 1 month = ppb 8-hr maxi-
mum; lifetime exposure ppb-hr). Separate models were run for each exposure metric. The full models that include other
covariates (sex, BMI, etc.) can be found in Supplemental Material (http://www.ehponline.org/docs/2007/10294/suppl.pdf). 
*p < 0.05.
Figure 2. Boxplot distributions of levels of FRAP by
sex in two groups of students who spent their sum-
mer break in two geographic locations, LA and SF.
Overall, men (n = 52) had signiﬁcantly higher FRAP
levels than women (n = 68, p = 0.002). The box rep-
resents the interquartile range; the horizontal line
inside the box represents the median; and the ver-
tical lines represent the minimum and maximum
values. 
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Figure 1. Boxplot distribution of levels of log-
transformed 8-iso-PGF stratified by sex in two
groups of students who spent their summer break
in two geographic locations, SF (n = 61) and LA (n =
51). Overall, subjects from LA had significantly
higher levels of 8-iso-PGF than those from SF (p =
0.02). The box represents the interquartile range;
the horizontal line inside the box represents the
median; and the vertical lines represent the mini-
mum and maximum values. 
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Table 2. Biomarkers of lipid peroxidation (8-iso-PGF) and antioxidant capacity (FRAP).
Parameter 8-Iso-PGFa,b FRAPa,c
Geographic location
SF (n = 59) 97.2 (17.4–674.7)* 1,059.4 (637.2–1686.0)
LA (n = 61) 195.3 (18.6–940.7) 1,002.5 (660.1–1908.9)
Sex
Male (n = 52) 133.1 (17.4–807.2) 1,196.3 (637.2–1908.9)*
Female (n = 68) 154.9 (18.6–940.7) 970.8 (660.1–1429.5)
Ethnicity
Caucasian (n = 42) 126.1 (18.6–940.7) 1,041.4 (637.2–1686.0)
Asian (n = 60) 169.4 (14.4–877.5) 1,065.5 (685.8–1908.9)
Other (n = 18) 154.1 (34.9–574.1) 884.1 (757.5–1686.0)
aData are presented as median (range). bRaw values presented in pg/mL; log–transformed concentrations were used for
regression analyses. cValues are µmol/mL. *p < 0.05.We estimated individual O3 exposures for
up to 30 days prior to blood collection based
on each subject’s summer residence and date
of return to SF. Level of 8-iso-PGF showed
the strongest associations with 2-week [β =
0.035 (pg/mL)/8-hr ppb O3, p = 0.007] and
1-month [β = 0.031 (pg/mL)/8-hr ppb O3,
p = 0.006] prior O3 exposure estimates,
despite significant overlap between the two
geographic categories. However, estimated
lifetime exposure had the most precise relation
with 8-iso-PGF [β = 0.025 (pg/mL)/ppb O3,
p = 0.0007]. There is a 17.41-pg/mL (95%
CI, 15.43–19.39 pg/mL) increase in 8-iso-
PGF for the 17-ppb cumulative lifetime O3
exposure difference between LA and SF sub-
jects. Level of FRAP, on the other hand, was
not associated with recent O3 exposures
{2-week [β = –7.93 (pg/mL)/8-hr ppb O3, p =
0.95] and 1-month [β = 1.69 (pg/mL)/8-hr
ppb O3, p = 0.76] prior} or lifetime exposure
[β = –2.21 (pg/mL)/ppb O3, p = 0.45].
Correlations between the three O3 exposure
estimates are presented in Supplemental
Material, Table 1 (http://www.ehponline.org/
docs/2007/10294/suppl.pdf).
The relations between biomarkers of oxida-
tive stress and separate O3 (2 weeks prior,
1 month prior, estimated lifetime) exposure
estimates were explored further with multivari-
able regression to control for the following
covariates: sex, ethnicity, BMI, and FRAP. O3
exposure estimates were the strongest predic-
tors for level of 8-iso-PGF (Table 3). A ﬁnal
model that included all three exposure metrics
further confirmed that each exposure period
had an independent association with
8-iso-PGF levels. The covariates did not con-
tribute significantly to any model and their
exclusion did not change the magnitude of the
associations [Supplemental Material, Table 2
(online at http://www.ehponline.org/docs/
2007/10294/suppl.pdf)].
The contribution of the estimated lifetime
O3 exposure, independent of the recent
2-week and 1-month O3 exposures, was deter-
mined by evaluation of the distribution of
residuals from a separate regression model that
used the two short-term exposures as indepen-
dent variables and lifetime exposure as the
outcome [Supplemental Material, Table 3
(http://www.ehponline.org/docs/2007/
10294/suppl.pdf)]. The lifetime exposure
residuals obtained from this model were used
as the O3 exposure variable in a final multi-
variable model and conﬁrmed an independent
effect of cumulative lifetime exposure [β =
0.025 (pg/mL)/ppb O3, p = 0.004].
Increased FRAP in females was marginally
associated with lower lung function, FEF75
[Supplemental Material, Figure 1A; β =
–0.0001 (µmol/mL)/(mL/sec), p = 0.15], after
the removal of an outlier. In males, however,
FRAP levels paralleled FEF75, although it was
not statistically significant [Supplemental
Material, Figure 1B; β = –0.0001 (µmol/mL)/
(mL/sec), p = 0.67]. No relation between 8-iso-
PGF and FEF75 was found in either sex
[Supplemental Material, Figure 2 (http://www.
ehponline.org/docs/2007/10294/suppl.pdf)].
Biomarker levels from the acute exposure
substudy are presented in Figure 3. The levels
of 8-iso-PGF increased from 28.5 pg/mL at
baseline to 51.1 pg/mL immediately after O3
exposure ended (p = 0.10) and by 18 hr had
returned close to baseline (30.5 pg/mL,
Table 4). There was a (22%) decrease in FRAP
immediately after exposure (p = 0.17).
Antioxidant capacity returned to near pre-
exposure levels by 18 hr (723.5 vs. 771.4
µmol/mL, respectively). Individual FRAP val-
ues before and 18 hr after exposure were signif-
icantly correlated (r = 0.82, p < 0.0001);
however, 8-iso-PGF measures were not (r =
0.48, p = 0.20). Correlations between levels at
baseline and 4 hr after exposure, although rela-
tively high, were not statistically signiﬁcant for
either FRAP (r = 0.77, p = 0.23) or 8-iso-PGF
(r = 0.71, p = 0.23), possibly because of a rela-
tively small number of subjects in the chamber
study. Overall, average FRAP and 8-iso-PGF
levels were lower in this controlled exposure
substudy than in the larger cohort study.
However, these same subjects were on the
lower end of the isoprostane distribution for
the entire study group. Additionally, the acute
exposures were all conducted during the spring
in SF when ambient pollution levels are low.
Furthermore, 9 of the 15 subjects were lifetime
SF residents with comparatively less O3 expo-
sure than LA subjects.
Discussion
Previously, we demonstrated that estimated
lifetime exposure to ambient O3 in a cohort
of young healthy adults was associated with
reduced measures of lung function that reﬂect
the physiology of the small airways, FEF75
and FEF25–75 (Tager et al. 2005). We also
found that residence during summer seasons
of elevated O3 in two geographic regions dif-
ferentially affected cytogenetic damage in oral
epithelia (Chen et al. 2006). Subjects who
spent the summer in LA had significantly
higher micronucleus frequencies than those
who stayed in SF. Here, we observed a similar
group effect of high oxidant region (summers
in LA vs. SF) on elevated lipid peroxidation,
as measured by 8-iso-PGF, in the same
cohort. Addtionally, we determined if an
individual’s exposure over varying periods of
time affected his/her 8-iso-PGF levels.
Multivariable regression demonstrated that
estimated 2-week prior, 1-month prior, and
lifetime O3 exposures of young healthy indi-
viduals were significantly and independently
associated with increased 8-iso-PGF levels,
while controlling for sex and ethnicity. In
particular, these findings indicate that long-
term exposure to elevated O3 can contribute
to oxidant burden over periods longer than
1 month. Results from the controlled expo-
sure substudy conﬁrmed that oxidative stress
increases after 4 hr of O3 exposure. Levels of
8-iso-PGF returned to near baseline by 18 hr
without further exposure.
Although free 8-iso-PGF in humans has a
relatively short half-life (~ 16 min), the time
course observed in the participants of the
acute study mirrored those reported in previ-
ous animal models of oxidant stress (Morrow
et al. 1992). In the larger cohort study, we
expected an individual’s most recent exposure
(1- to 7-day time lag) prior to sample collec-
tion to correlate best with 8-iso-PGF.
Contrary to this expectation, we observed sig-
nificant effects for slightly longer recent O3
exposures (2 weeks and 1 month prior to
blood collection) on 8-iso-PGF. Somewhat
surprisingly, lifetime exposure also had a
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Table 4. 8-Iso-PGF and FRAP after acute exposure to 200 O3 ppb for 4 hr (n = 15).
Preexposure 4 hr postexposurea 18 hr postexposure
8-iso-PGF (pg/mL) 28.5 ± 12.5 51.1 ± 25.1* 30.5 ± 7.4
FRAP (µmol/mL) 771.4 ± 234.7 600.3 ± 86.4 723.5 ± 205.8
Data are presented as mean ± SD. 
an = 4. *p < 0.10, ANOVA (Tukey post hoc) compared with preexposure and 18 hr postexposure.
Figure 3. Distribution of (A) 8-iso-PGF and (B) FRAP after acute exposure to 200 ppb for 4 hr (n = 15). Data
are presented as mean ± SD. 
*Mean value signiﬁcantly different than other time points.
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A Bsigniﬁcant association with increased levels of
this biomarker of lipid peroxidation, possibly
because of greater precision for lifetime esti-
mate than that for shorter lag times.
Even though we cannot be certain that the
lifetime exposure associated with repeated oxi-
dant injury has led to a chronic state of oxida-
tive stress that persists over many years, the
data do indicate chronic exposure of at least
2–4 weeks contributes to subacute oxidative
stress. The observed oxidant effects on lipid
peroxidation are consistent with those in other
studies examining chronic oxidative stress.
Ahmadzadehfar et al. (2006) reported that
8-iso-PGF levels increased during passive
exposure of nonsmokers to cigarette smoke
but tended to return to baseline by 6 hr post-
exposure. After repeated exposure over
12 days, however, 8-iso-PGF levels in these
nonsmokers rose to levels that approached
those of active smokers. These results, together
with ours, suggest that repeated exposures to
oxidant pollutants can lead to sustained oxida-
tive stress that, in turn, causes increased lipid
peroxidation. The only other long-term study
of the effect of air pollution on lipid peroxida-
tion found a 30% decrease in the thiobarbi-
turic acid reactive substances (TBARS) assay
with extended stay in highly polluted areas of
Mexico City (Medina-Navarro et al. 1997).
The TBARS assay measures a different lipid
peroxidation end point, malondialdehyde, and
has been shown to be nonspeciﬁc and provide
erroneously high estimates (Esterbauer 1996;
Janero 1990).
O3 alone also may not be responsible for
the associations observed. As we reported
previously, in California the O3 season does not
overlap with that of PM2.5 but does coincide
with the seasonal rise of PM10–2.5 and NO2
(Tager et al. 2005), and these air pollutants are
highly correlated in this study population
[Supplemental Material, Table 4 (http://www.
ehponline.org/docs/2007/10294/suppl.pdf)].
Additional multivariable analysis conﬁrmed a
signiﬁcant effect of these co-pollutants; how-
ever, their inclusion in the models did not
change the magnitude of the associations with
O3. Furthermore, the validity of the association
with ambient O3 exposure estimates in our
study were strengthened by chamber substudy
results, where O3-induced 8-iso-PGF was also
increased after 4 hr of exposure compared with
baseline. Here, the effect of O3, is clear and
cannot be attributed to other pollutants. These
results are consistent with those of other cham-
ber studies that have observed an increase in
lipid peroxidation after acute O3 exposure
(Corradi et al. 2002; Devlin et al. 1996;
Hazbun et al. 1993; Montuschi et al. 2002).
Our FRAP data showing that subjects liv-
ing in LA during the summer had decreased
antioxidant capacity compared with those who
stayed in SF corroborate an earlier study by
Medina-Navarro et al. (1997). Their study
showed decreased antioxidant status, measured
by serum superoxide dismutase, in subjects liv-
ing in highly polluted areas compared with that
in controls. Additionally, we observed a mild
suppression of antioxidant levels, as measured
by the FRAP assay, in the chamber substudy
immediately after 4 hr of exposure to O3.
Although no other studies have used the FRAP
assay to assess the effect of air pollution on
antioxidant capacity, β-carotene supplementa-
tion has been shown to increase FRAP levels
(Bub et al. 2002), and exposure to pesticides
caused levels to decrease (Ranjbar et al. 2002).
We observed broad interindividual vari-
ability in both biomarkers of oxidative stress,
and explored the role of host factors such as
sex, ethnicity, weight, and BMI. We found no
signiﬁcant associations between 8-iso-PGF lev-
els and these covariates in either bivariate or
multivariable regression analyses. In contrast,
other studies of older adult subjects have
reported that females have higher levels of
8-iso-PGF than males (Berr et al. 1998b; Block
et al. 2002; Coudray et al. 1997). This effect of
sex may be due to higher body mass and per-
centage fat in adult women, as BMI was associ-
ated significantly with lipid peroxidation in
one study (Block et al. 2002). The women in
our population of healthy young students,
however, tended to have low BMI levels.
The men in our study had significantly
higher antioxidant capacity than females, as
measured by FRAP, that could have masked
an overall effect of sex on 8-iso-PGF. The role
of sex in antioxidant capacity was reported
previously in a population of older adults
(Berr et al. 1998a). We observed a moderate
correlation between FRAP and BMI (r = 0.19,
p = 0.09) and a signiﬁcant correlation between
FRAP and weight (r = 0.40, p < 0.0001).
Furthermore, overall antioxidant levels were
not significantly correlated with 8-iso-PGF
levels. This suggests that an aggregate measure
of antioxidant capacity such as FRAP may not
be as informative to an individual’s lipid per-
oxidation status in response to O3 (Mudway
and Kelly 2000). However, total antioxidant
capacity have been used successfully to charac-
terize disease status in asthma and COPD
(Nadeem et al. 2003; Rahman et al. 1996).
Although O3 exposure has been demon-
strated to affect lipid peroxidation in this
study, another factor that may contribute to
interindividual variability is self-reported eth-
nicity. The majority of subjects were either
Caucasian or Asian, which reﬂects the demo-
graphics of the UCB student population.
While we observed a marginal effect of race/
ethnicity on 8-iso-PGF (“Others,” p = 0.07),
we acknowledge that self-reported race/
ethnicity is not a precise biological concept
(Hanis et al. 1986; Hoggart et al. 2003; Parra
et al. 2001; Pritchard et al. 2000). One study
reported that African Americans have lower
8--iso-PGF levels than Caucasians (Block et al.
2002), whereas other studies have not observed
any differences among ethnicities (Ke et al.
2003; Lopes et al. 2003). Some of the variabil-
ity seen in this study may be explained by poly-
morphisms of genes involved in antioxidant
defenses, many of which vary by race/ethnicity.
For example, we found that both genotype fre-
quencies and enzyme activity of manganese
superoxide dismutase, a polymorphic enzyme
involved in antioxidant defense, varied by eth-
nicity in this same cohort (Bastaki et al. 2006).
The effects of such polymorphisms on lipid
peroxidation are currently being explored.
The relations between 8-iso-PGF, FRAP,
and previously established O3-induced cyto-
genetic damage (Chen et al. 2006) and lung
function decrements (Tager et al. 2005) were
also assessed. Lipid peroxidation was not associ-
ated with lung function [Supplemental
Material, Figure 2 (online at http://www.
ehponline.org/docs/2007/10294/suppl.pdf)]
and only marginally associated with cytogenetic
damage as assessed by the micronucleus fre-
quency during the fall (r = 0.15, p = 0.09;
Spearman correlation). FRAP was inversely
associated with cytogenetic damage (r = –0.21,
p = 0.06) and lung function [Supplemental
Material, Figure 1 (online at http://www.
ehponline.org/docs/2007/10294/suppl.pdf)].
The results of both the main chronic study
and the chamber substudy presented here pro-
vide additional evidence that inhalation of O3
causes lipid peroxidation that can be detected in
peripheral blood. 8-Iso-PGF appears to be a
good biomarker of the oxidative damage related
to inhaled O3 and high oxidant environments.
We have demonstrated an effect of a single
controlled O3 exposure and chronic ambient
exposure on elevated 8-iso-PGF. Additional
studies involving single, acute exposures that
examine the 8-iso-PGF time course and
repeated acute exposures in humans are war-
ranted to elucidate the true effect of chronic
exposure and accumulation of 8-iso-PGF over
time. The implications of the results presented
here are particularly signiﬁcant because oxida-
tive stress that results from exposure to ambient
pollutants may contribute to lung cancer,
asthma, and cardiopulmonary morbidity and
mortality (Dominici et al. 2003; Kunzli et al.
2003; Pope et al. 2002; Samet et al. 2000).
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